CHMFL-BTK-11

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameCHMFL-BTK-11
Drug Alias NameCHMFL-BTK-11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsArthritis, RheumatoidLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHefei Academy Of Physical Sciences, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesHefei Academy Of Physical Sciences, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsArthritis, RheumatoidLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A